Patients undergoing CF-LVADs insertion show features suggestive of acquired von Willebrand disease caused by deficiency or dysfunction of von Willebrand Factor (vWF), a key clotting protein whose interaction with platelets and vessel wall generates primary haemostasis. Here, VWF is linked to platelet-type von Willebrand disease.